Real-World Body Composition and Blood Pressure Changes Following Glucagon-Like Peptide 1 Receptor Agonist Initiation: A Causal Inference Study of Connected Device Data
Publication date: September 2026 Source: Mayo Clinic Proceedings: Digital Health, Volume 4, Issue 3 Author(s): Agathe Chabassier, Benjamin Vittrant, Pierre Binon, Erwan Scornet, Julie Josse
Real-World Body Composition and Blood Pressure Changes Following Glucagon-Like Peptide 1 Receptor Agonist Initiation: A Causal Inference Study of Connected Device Data. // Mayo Clinic Proceedings: Digital Health. – URL: https://www.sciencedirect.com/science/article/pii/S2949761226000416?dgcid=rss_sd_all
Real-World Body Composition and Blood Pressure Changes Following Glucagon-Like Peptide 1 Receptor Agonist Initiation: A Causal Inference Study of Connected Device Data. Mayo Clinic Proceedings: Digital Health. https://www.sciencedirect.com/science/article/pii/S2949761226000416?dgcid=rss_sd_all
“Real-World Body Composition and Blood Pressure Changes Following Glucagon-Like Peptide 1 Receptor Agonist Initiation: A Causal Inference Study of Connected Device Data.” Mayo Clinic Proceedings: Digital Health.
@article{article57967,
title = {Real-World Body Composition and Blood Pressure Changes Following Glucagon-Like Peptide 1 Receptor Agonist Initiation: A Causal Inference Study of Connected Device Data},
journal = {Mayo Clinic Proceedings: Digital Health},
url = {https://www.sciencedirect.com/science/article/pii/S2949761226000416?dgcid=rss_sd_all}
}